Table 2.
Summary of significance of outcome measures for two dimensional (2-D) ultrasound guidance compared with landmark method for catheterisation
|
Internal jugular vein
|
Subclavian vein
|
Femoral vein
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
No of placements
|
No of placements
|
No of placements
|
||||||||||
| Variable | 2-D ultrasound guidance | Landmark method | Effect size (95% CI) | P value | 2-D ultrasound guidance | Landmark method | Effect size (95% CI) | P value | Doppler ultrasound guidance | Landmark method | Effect size (95% CI) | P value |
| Adults | ||||||||||||
| Relative risk: | ||||||||||||
| Failed catheter placement | 296 | 312 | 0.14 (0.06 to 0.33) | <0.0001 | 25 | 27 | 0.14 (0.04 to 0.57) | 0.006 | 20 | 20 | 0.29 (0.07 to 1.21) | 0.09 |
| Complication with placement | 284 | 295 | 0.43 (0.22 to 0.87) | 0.02 | 25 | 27 | 0.10 (0.01 to 0.71) | 0.02 | — | — | NA | NA |
| Failure on first attempt | 162 | 179 | 0.59 (0.39 to 0.88) | 0.009 | — | — | NA | NA | — | — | NA | NA |
| Mean No: | ||||||||||||
| Attempts to successful catheterisation | 131 | 136 | −1.50 (−2.53 to −0.47) | 0.004 | — | — | NA | NA | 20 | 20 | −2.70 (−5.26 to −0.14) | 0.04 |
| Seconds to successful catheterisation | 180 | 192 | −69.33 (−92.36 to −46.31) | <0.0001 | — | — | NA | NA | 20 | 20 | −3.20 (−43.27 to 36.87) | 0.9 |
| Infants | ||||||||||||
| Relative risk: | ||||||||||||
| Failed placement | 79 | 88 | 0.15 (0.03 to 0.64) | 0.01 | — | — | NA | NA | — | — | NA | NA |
| Complication with placement | 79 | 88 | 0.27 (0.08 to 0.91) | 0.03 | — | — | NA | NA | — | — | NA | NA |
| Failure on first attempt | — | — | NA | NA | — | — | NA | NA | — | — | NA | NA |
| Mean No: | ||||||||||||
| Attempts to successful catheterisation | 43 | 52 | −2.00 (−2.78 to −1.22) | <0.0001 | — | — | NA | NA | — | — | NA | NA |
| Seconds to successful catheterisation | 59 | 68 | −349.38 (−801.89 to 103.13) | 0.13 | — | — | NA | NA | — | — | NA | NA |
NA=not available. All outcomes favoured ultrasound guidance (relative risk <1).